Lipid management with HMG CoA reductase inhibitors in the elderly

Caitlin Nass, Roger S. Blumenthal

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Coronary artery disease (CAD) is the number one cause of death for men and women in the United States and is a significant cause of morbidity and mortality for individuals age 65 years and older. A significant medical advance in the prevention and treatment of CAD has been the implementation of lipid-lowering therapy to treat elevated cholesterol. Some clinicians, however, have lingering questions about when to treat hyperlidemia in elderly patients. This article will review the available data on the impact of statin therapy on cardiovascular risk reduction in the elderly.

Original languageEnglish (US)
Pages (from-to)20-25
Number of pages6
JournalAnnals of Long-Term Care
Issue number6
StatePublished - Jun 1 2003

ASJC Scopus subject areas

  • Gerontology
  • Geriatrics and Gerontology


Dive into the research topics of 'Lipid management with HMG CoA reductase inhibitors in the elderly'. Together they form a unique fingerprint.

Cite this